. Michael Grunwald from received in the He observed: Politico Trans-Pacific Partnership. recent draft of the free-trade deal would give U.S. Trans-Pacific Partnership ‘A pharmaceutical firms unprecedented protections against competition from cheaper generic drugs, possibly transcending the patent protections in U.S. Grunwald commented that law.’ draft chapter will provide ammunition for critics who have warned that ‘the TPP’s protections for pharmaceutical companies could dump trillions of dollars of additional health care costs on patients, businesses and governments around the He also Rim’. emphasized that the leaked text revealed that negotiators have fought aggressively and, ‘U.S. at least until Guam, successfully on behalf of Big Pharma.’ The civil society group Knowledge Ecology International published a leaked draft of the Intellectual Property Chapter of the in August 2015, before the Trans-Pacific Partnership final deal. The director, James Love, was concerned that the text revealed that the United States to be the most aggressive supporter of expanded intellectual property rights ‘continues for drug He was concerned that proposals contained in the TPP will harm companies.’ ‘the consumers and in some James Love feared: countless ways, the cases block innovation.’ ‘In Obama Administration has sought to expand and extend drug monopolies and raise drug He maintained: astonishing collection of proposals pandering to big drug prices.’ ‘The companies make more difficult the task of ensuring access to drugs for the treatment of cancer and other diseases and conditions.’ Love called for a different approach to intellectual property and than focusing trade: ‘Rather on more intellectual property rights for drug companies, and a death-inducing spiral of higher prices and access barriers, the trade agreement could seek new norms to expand the funding
. Michael Grunwald from Politico received in the Trans-Pacific Partnership. He observed: ‘A recent draft of the Trans-Pacific Partnership free-trade deal would give U.S. pharmaceutical firms unprecedented protections against competition from cheaper generic drugs, possibly transcending the patent protections in U.S. law.’ Grunwald commented that ‘the draft chapter will provide ammunition for critics who have warned that TPP’s protections for pharmaceutical companies could dump trillions of dollars of additional health care costs on patients, businesses and governments around the Rim’. He also emphasized that the leaked text revealed that ‘U.S. negotiators have fought aggressively and, at least until Guam, successfully on behalf of Big Pharma.’ The civil society group Knowledge Ecology International published a leaked draft of the Intellectual Property Chapter of the Trans-Pacific Partnership in August 2015, before the final deal. The director, James Love, was concerned that the text revealed that the United States ‘continues to be the most aggressive supporter of expanded intellectual property rights for drug companies.’ He was concerned that ‘the proposals contained in the TPP will harm consumers and in some cases block innovation.’ James Love feared: ‘In countless ways, the Obama Administration has sought to expand and extend drug monopolies and raise drug prices.’ He maintained: ‘The astonishing collection of proposals pandering to big drug companies make more difficult the task of ensuring access to drugs for the treatment of cancer and other diseases and conditions.’ Love called for a different approach to intellectual property and trade: ‘Rather than focusing on more intellectual property rights for drug companies, and a death-inducing spiral of higher prices and access barriers, the trade agreement could seek new norms to expand the funding
sub145-intellectual-property.docx